Ventas (NYSE:VTR) Updates FY 2026 Earnings Guidance

Ventas (NYSE:VTR) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 3.820-3.890 for the period, compared to the consensus estimate of 3.880. The company issued revenue guidance of -.

Ventas Trading Down 1.4%

Ventas stock opened at $83.42 on Tuesday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas has a 52 week low of $61.76 and a 52 week high of $91.06. The company has a market capitalization of $40.56 billion, a price-to-earnings ratio of 151.67, a price-to-earnings-growth ratio of 1.82 and a beta of 0.71. The stock has a 50-day moving average price of $85.15 and a 200 day moving average price of $82.54.

Ventas (NYSE:VTR) last released its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm earned $0.84 EPS. The company’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts anticipate that Ventas will post 3.88 EPS for the current year.

Ventas Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s payout ratio is 378.18%.

Analysts Set New Price Targets

A number of analysts have recently commented on VTR shares. UBS Group boosted their price target on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Scotiabank boosted their price target on Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 21st. The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 price target on shares of Ventas in a research report on Tuesday, May 19th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $100.00 price target on shares of Ventas in a research report on Tuesday. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Ventas in a research report on Friday, March 27th. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.47.

Insider Activity

In other news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Ventas

Several large investors have recently bought and sold shares of VTR. Wiser Advisor Group LLC purchased a new stake in Ventas during the 3rd quarter worth about $27,000. IFC & Insurance Marketing Inc. acquired a new stake in shares of Ventas during the 4th quarter worth about $30,000. Zions Bancorporation National Association UT raised its position in shares of Ventas by 250.3% during the 4th quarter. Zions Bancorporation National Association UT now owns 508 shares of the real estate investment trust’s stock worth $39,000 after acquiring an additional 363 shares in the last quarter. DV Equities LLC acquired a new stake in shares of Ventas during the 4th quarter worth about $51,000. Finally, Rossby Financial LCC raised its position in shares of Ventas by 45.8% during the 4th quarter. Rossby Financial LCC now owns 729 shares of the real estate investment trust’s stock worth $56,000 after acquiring an additional 229 shares in the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.